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RESUMO 
 
O objetivo deste ensaio clínico controlado, randomizado, duplo cego, foi comparar os 
resultados clínicos do tratamento de recessões gengivais utilizando retalho posicionado 
coronariamente (RPC) combinado com enxerto de matriz de colágeno de origem suína (MC) 
e/ou proteínas da matriz do esmalte (EMD). Foram selecionados 68 pacientes com recessões 
gengivais Classe I ou II de Miller ≥ 3 mm, em caninos ou pré-molares superiores.. Os defeitos 
foram aleatoriamente designados para o grupo RPC (n=17); RPC+MC (n=17); RPC+EMD 
(n=17) ou RPC+MC+EMD (n=17). Os parâmetros clínicos avaliados foram profundidade de 
sondagem, nível de inserção clínico, altura da recessão gengival, altura e espessura de tecido 
queratinizado e estética. As medidas clínicas foram tomadas imediatamente antes da cirurgia, 
3 e 6 meses após as cirurgias. O recobrimento médio obtido foi de 68,04 ± 24,11% para RPC; 
87,20 ± 15,01% para RPC+MC; 88,77 ± 20,66% para RPC+EMD e 91,59 ± 11,08% para 
RPC+MC+EMD após 6 meses, com resultados superiores para os biomateriais (p <0,05). 
Recobrimento completo foi conseguido em 70,59% dos casos tratados com EMD, enquanto 
apenas 23,53% no RPC; 52,94% no MC e 51,47% para MC+EMD (p <0,05). Ao final do 
estudo, o ganho na espessura de tecido queratinizado foi maior para os grupos com MC 
(p<0,05). Todos tratamentos apresentaram melhora na avaliação estética dos profissionais 
(p<0,05). Dentro dos limites do presente estudo pôde-se concluir que a associação de RPC com 
MC, EMD ou MC+EMD proporcionou resultados superiores em relação a redução da recessão 
quando comparados a RPC (p<0,05), mas sem diferença entre os biomateriais. A utilização do 
EMD obteve maior porcentagem de recobrimento completo e o uso do MC permitiu maior 
ganho de espessura gengival quando comparado ao baseline.  
Palavras-chave: Retração gengival/cirurgia. Colágeno/uso terapêutico. Proteínas do esmalte 
dentário/uso terapêutico. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
The aim of this double blind, randomized, controlled clinical trial, was to evaluate the clinical 
outcomes after the treatment of gingival recession with the coronally advanced flap (CAF) 
combined to a porcine collagen matrix graft (CM) and/or enamel matrix derivative (EMD). 
Sixty eight patients with Miller Class I or II gingival recessions ≥ 3 mm in canines or superior 
premolars were selected. The defects were randomly assigned to the CAF group (n = 17); CAF 
+ CM (n = 17); CAF + EMD (n = 17) or CAF + CM + EMD (n = 17).  The clinical parameters 
evaluated were probing depth, clinical attachment level, gingival recession height, width and 
thickness of keratinized tissue and aesthetics. Clinical measurements were taken at baseline, 3 
and 6 months after surgery. The mean percentage of root coverage was 68.04 ± 24.11% for 
CAF; 87.20 ± 15.01% for CAF + CM; 88.77 ± 20.66% for CAF + EMD and 91.59 ± 11.08% 
for CAF + CM + EMD after 6 months, with superior results for biomaterials (p <0.05). 
Complete root coverage was achieved in 70.59% of the cases treated with EMD, and only in 
23.53% for CAF; 52.94% for CAF+CM and 51.47% for CAF+CM + EMD (p <0.05). At the 
end of the study, the gain in keratinized tissue thickness was higher for the CM groups (p <0.05). 
All treatments presented a significant increase in professional aesthetic evaluation (p <0.05). 
Within the limits of the present study it was concluded that the association of CAF with CM, 
EMD or CM + EMD provides superior results for recession reduction when compared to CAF 
alone (p<0,05), but with no difference among biomaterials. The use of EMD obtained higher 
percentage of complete root coverage, and the use of CM obtained superior gain of gingival 
thickness when compared to baseline. 
Keywords: Gingival retraction / surgery. Collagen / therapeutic use. Dental Enamel Proteins / 
therapeutic use. 
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1 INTRODUÇÃO 
 
Na busca de resultados mais previsíveis e eficazes, a odontologia tem buscado 
desenvolver diferentes tratamentos para atender às queixas de pacientes cada vez mais exigentes 
em relação a presença de recessões gengivais e suas consequências estéticas e funcionais, como 
hipersensibilidade radicular e lesões cervicais cariosas ou não cariosas (Cairo et al. 2016; Cairo 
et al. 2014). 
Visando ao tratamento dessa condição, diversas técnicas já foram desenvolvidas 
para alcançar cobertura da raiz com maior previsibilidade e efetividade (Buti et al. 2013; 
Chambrone e Tatakis 2015). O retalho posicionado coronariamente apresenta bons resultados, 
apesar da grande variabilidade descrita na literatura (Cairo et al. 2008). Na tentativa de melhorar 
a previsibilidade, a associação do enxerto subepitelial de tecido conjuntivo (ESTC) tem sido 
considerado o padrão ouro para o recobrimento de recessões gengivais (Cairo et al. 2008; Buti 
et al. 2013; Chambrone e Tatakis 2015). No entanto, a utilização desse enxerto, promove 
aumento do tempo operatório, dor, e complicações pós-operatórias, como sangramentos ou 
hematomas (Zucchelli et al. 2010; Chambrone and Tatakis 2015). 
A fim de evitar a morbidade associada aos procedimentos de enxerto de tecido 
autógeno, pesquisas tem buscado um substituto adequado, apresentados novas técnicas ou 
combinações de diferentes técnicas com o retalho posicionado coronalmente (RPC) (Allen and 
Miller 1989; De Sanctis and Zucchelli 2007), como regeneração tecidual guiada (RTC) (Harris 
2002) , matriz acelular dérmica (MDA) (Côrtes et al. 2004; Moslemi et al. 2011) , matriz de 
colágeno (MC) (Jepsen et al. 2013; Moreira et al. 2016), proteínas da matriz do esmalte (EMD) 
(Koop et al. 2012; McGuire et al. 2012; McGuire et al. 2016) ou aplicação de plasma rico em 
plaquetas (Keceli et al. 2008) e ainda a combinações de diversos biomateriais associado ao 
RPC, como ETCS associado ao EMD (Berlucchi et al. 2002; Rasperini et al. 2011); RTC e 
enxerto alógeno de osso liofilizado desmineralizado (Kimble et al. 2004) ou EMD (Trabulsi et 
al. 2004); beta-tricálcio fosfato associado a fatores de crescimento derivado de plaquetas 
recombinante humano (Singh and Suresh 2012); MDA associada a EMD (Shin et al. 2007; 
Pourabbas et al. 2015) ou fibroblastos gengivais (Jhaveri et al. 2010). 
Uma revisão com metanálise (Buti et al. 2013) foi conduzida com o objetivo de 
estabelecer um ranking de eficácia clínica no recobrimento de recessões gengivais utilizando 
técnicas associadas ao retalho posicionado coronalmente. A utilização do enxerto de tecido 
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subepitelial foi considerada o padrão ouro no recobrimento gengival, pela redução da recessão 
e ganho de inserção. A utilização do EMD permitiu alta taxa de recobrimento completo, 
enquanto a utilização de Matriz de colágeno foi considerada tão efetiva quanto o enxerto 
autógeno para aumento de tecido queratinizado. 
O uso de MC é uma alternativa que surgiu recentemente e tem demonstrado 
resultados promissores, evitando a necessidade de um segundo sitio cirúrgico (Rotundo e Pini-
Prato 2012; Molnár et al. 2013; Atieh et al. 2015; Moreira et al. 2016). A estrutura da MC 
consiste em duas camadas funcionais: uma camada celular oclusiva, com fibras colágenas 
arranjadas de forma compacta, e uma camada porosa. Esta última favorece a formação do 
coágulo sanguíneo e o crescimento dos tecidos adjacentes, resultando, clinicamente, em maior 
formação de tecido queratinizado (Lorenzo et al. 2012). Do ponto de vista histológico, a 
reparação ocorre pela completa incorporação da MC aos tecidos adjacentes, sendo observada a 
formação de maior quantidade de novo cemento e de nova inserção na parte mais apical do 
defeito quando comparado ao RPC somente (Vignoletti et al. 2011). 
Já a utilização do EMD em procedimentos de recobrimento radicular tem 
demonstrado boas características clinicas, além de regeneração periodontal, como verificado 
em estudos com avaliação histológica em humanos com a formação de novo osso, cemento e 
ligamento periodontal (Sculean et al. 2008; McGuire et al. 2016). O EMD é composto de 
diferentes proteínas, 90% das quais são amelogeninas, que tem a capacidade de induzir os 
processos de regeneração dos tecidos periodontais de maneira semelhante ao desenvolvimento 
normal dos tecidos (Hammarström et al. 1997). Diversos estudos clínicos e em animais têm 
demonstrado a utilização das proteínas derivadas da matriz de esmalte em procedimentos 
periodontais regenerativos para a formação de um novo periodonto (Fujita et al. 2011; 
Hammarström et al. 1997; Sallum et al. 2004; Corrêa et al. 2012). 
Apesar dos resultados alcançados por esses tratamentos, não foram identificados 
estudos clínicos controlados para avaliação do papel da MC associada ao EMD em 
procedimentos de recobrimento radicular. Assim, o objetivo deste estudo foi avaliar 
clinicamente os resultados obtidos no tratamento de recessões gengivais Classe I e II de Miller 
tratadas por meio de retalho posicionado coronariamente combinado com matriz de colágeno 
de origem suína e/ou proteínas da matriz do esmalte. 
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Abstract  
Background: Considering xenogeneic collagen matrix (CM) and enamel matrix derivative 
(EMD) characteristics, it is suggested that their combination could promote superior clinical 
outcomes in root coverage procedures. Thus, the aim of this parallel, double-blinded, dual-
centre, randomized clinical trial was to evaluate the clinical outcomes after treatment of 
localized gingival recession by coronally advanced flap (CAF) combined with CM and/or 
enamel matrix derivative (EMD). 
Methods: Sixty-eight patients presenting one Miller Class I or II gingival recessions were 
randomly assigned to receive either CAF (n=17); CAF + CM (n=17); CAF+EMD (n=17) or 
CAF+CM+EMD (n=17). Recession height (GR), probing depth (PD), clinical attachment level 
(CAL), keratinized tissue width (KTW) and thickness (KTT), were measured at baseline, 3 and 
6 months post-surgery. 
Results: The obtained root coverage was 68.04 ± 24.11% for CAF; 87.20 ± 15.01% for 
CAF+CM; 88.77 ± 20.66% for CAF+EMD and 91.59 ± 11.08% for CAF+CM+EMD after 6 
months, with the groups receiving biomaterials showing greater values (p <0.05) Complete root 
coverage for CAF+EMD was 70.59%, significantly superior to CAF alone (23.53%); CAF+CM 
(52.94%) and CAF+CM+EMD (51.47%) (p<0.05). Keratinized tissue thickness gain was 
significant only in CM treated groups (p <0.05).  
Conclusions: The 3 approaches are superior to CAF alone for root coverage. EMD provides 
highest levels of complete root coverage, however, the addition of CM increases gingival 
thickness. The combination approach does not seem justified.  
 
Keywords: Collagen; enamel matrix proteins; gingival recession; tissue regeneration; clinical 
trial  
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Introduction 
A recent systematic review concerning untreated recession defects in subjects with good 
oral hygiene demonstrated a high probability of recession progress after a long-term follow-
up1. For that reason, the increasing interest in periodontal plastic surgeries for root coverage is 
pushing the researchers forward in the effort to design and test different surgical treatments that 
guarantee good clinical outcomes and response to a  high aesthetic demands with minimal 
invasiveness2. 
The combination of subepithelial connective tissue graft (SCTG) with coronally 
advanced flap (CAF) has been demonstrated to have the highest probability to achieve complete 
root coverage (CRC) and best aesthetic outcomes at professional and patient level for localized 
gingival recessions by several randomized clinical trials and systematic reviews3–5. However, 
the wound at the donor site for harvesting the SCTG is frequently associated with discomfort, 
swelling and occasionally pain4,6,7.  
Consequently, alternatives to SCTG have been pursued. The use of xenogeneic collagen 
matrix (CM) has been suggested as an effective treatment option to achieve root coverage and 
some increase in soft tissue thickness with a less invasive, time consuming, and unlimited 
supply8–10. Thus, it may be considered a feasible substitute to the SCTG procedure. 
Furthermore, the use of enamel matrix derivative proteins (EMD) in root coverage procedures 
has shown excellent clinical features as the improvement of the probability to achieve complete 
root coverage in localized Miller class I and II gingival recessions when compared to the CAF 
alone11,12. Also, periodontal regeneration, as seen in histological studies in animals and humans 
with the formation of new bone, cementum, and periodontal ligament are associated with EMD 
use13,14. 
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Based on these biomaterials characteristics, it could be hypothesized that the association 
of CM and EMD would increase the predictability of the treatment of gingival recession defects. 
However, within the author's knowledge, there is no available study that compared, at the same 
trial, the isolated and combined use of these 2 biomaterials (CM/EMD). Therefore, it is the goal 
of this randomized clinical trial to evaluate the clinical outcomes after the treatment of gingival 
recession with the coronally advanced flap combined to a porcine collagen matrix graft and/or 
enamel matrix derivative. 
Material and methods  
Experimental design 
This is a parallel, double-blinded, dual-centre, randomized clinical trial registered on 
U.S. National Institutes of Health Clinical Trials Registry - (NCT02456337). Four different 
surgical approaches were compared for the treatment of single Miller class I and II gingival 
recessions: CAF alone (CAF); CAF plus CM (CAF+CM)§§; CAF plus EMD (CAF+EMD)‖ and 
CAF plus CM and EMD (CAF+CM+EMD). 
All patients signed an informed consent after receiving a detailed explanation 
concerning the nature, risks, and benefits of this clinical investigation. The study protocol has 
been approved by the Institutional Review Board of the Piracicaba Dental School, State 
University of Campinas (CEP-UNICAMP 067/2013). 
Participants 
In the period of October 2013–April 2016, 68 patients were screened among those 
referred for periodontal treatment at the Periodontology Clinic of the Piracicaba Dental School, 
State University of Campinas (FOP-UNICAMP) and the Periodontology Clinic of UNESP - 
State University of São Paulo (São José dos Campos, Brazil). 
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Eligibility criteria 
Patients older than 18 years old with the presence of Miller class I or II gingival 
recession (>3mm) in the maxillary canines or premolars with an identifiable cemento-enamel 
junction (CEJ) and tooth vitality; absence of active periodontal disease; full-mouth bleeding 
and plaque score ≤ 20% and signed informed consent form.  
Exclusion Criteria  
Patients taking any kind of medication that could interfere with the periodontal tissue 
health or healing; presence of systemic problems; smoker, pregnancy or current intention to 
become pregnant, as well as lactating women; patients with previous periodontal plastic surgery 
procedures on the selected site; extruded or malpositioned teeth. 
Preparation period 
After the initial examination, all patients received oral hygiene instructions to modify 
traumatic tooth brushing habits and to inform about the etiology and treatment of gingival 
recessions. A supragingival scaling session and dental prophylaxis was performed 2 weeks 
before the scheduled surgical procedure. The plastic surgery procedures were performed when 
adequate plaque control was reached.  
Investigator training 
All investigators were required to attend three training and calibration meetings with the 
purposes of reviewing the study objectives and protocols, the standardization of case selection, 
clinical measurements, surgical procedures, explanations and communication procedures.  
Clinical Assessments  
At baseline, after 3 and 6 months, the following clinical parameters were evaluated: full-
mouth visible plaque index (FMPI); full-mouth sulcus bleeding index (FMBI); probing depth 
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(PD): measured in millimeters with a periodontal probe††; clinical attachment level (CAL): at 
the mid-buccal aspect of the tooth, the distance between the cementoenamel junction (CEJ) and 
the lowest level of PD; (GR): the distance from the GM to the CEJ at the mid-buccal aspect of 
the tooth. GR measurements were done through the use of a digital caliper accurate to 0.01 
mm¶. Keratinized tissue width (KTW) was measured from the GM to the mucogingival junction 
(MGJ) and evidenced with iodine solution stain***; keratinized tissue thickness (KTT) was 
measured at the mid-point of KTW. 
Calibration of the examiners 
All clinical measurements were performed by two blinded and calibrated periodontists 
(FLSN and JPMS, one in each center). Calibration was done by double measurements of GR in 
30 recession defects. Intra-class correlation was used to determine the intra-examiner and inter-
examiner reproducibility of the measurements. FLSN reached IC = 0.84 intra- examiner 
agreement values. JPMS intra-examiner agreement was IC = 0.88. Inter-examiner agreement 
was IC = 0.86 for all measurements. 
Aesthetic Evaluation 
 Two professional aesthetic evaluation were performed, using the visual analog scale 
(VAS) and the root coverage aesthetic score (RES)15. Pictures of the baseline and 6 months 
aspects were evaluated by four different independent periodontists, unaware of the treatment 
performed in each site. Patient-centered outcomes were also evaluated in the trial, and will be 
presented elsewhere (Part II). 
Randomization, allocation concealment and blinding  
The randomization of the patients was performed through a computer-generated 
randomization table, organized by an external individual (ILSG), not involved in the 
recruitment, treatment, or evaluation of the patients. Following this sequence, opaque, sealed 
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envelopes were prepared, containing the randomization treatment code for each patient. The 
treatment was only revealed to the surgeon once the flap was completed. Additionally, neither 
the patients nor the investigators who performed the clinical assessments knew which treatment 
each patient received.  
Treatment  
Two experienced and standardized surgeons (EAS and MPS) performed the surgical 
procedures, one in each center (EAS at UNICAMP, MPS at UNESP). A trapezoid-shaped flap 
(CAF) with a split–full–split approach was elevated16. After, the papillaes have been 
deepithelialized, the debridement of the exposed root surface was performed by manual 
instrumentation. At this moment, the designated treatment was revealed to the surgeon. The 
EMD was applied to the selected sites and left on a dried root surface for at least 2min. When 
CM was used, the matrix of the desired defect dimensions was trimmed and placed over the 
defect and sutured independently of the flap, with the porous surface in contact with the bone 
and the tooth.  Finally, interrupted sutures were performed to position the flap coronal to the 
CEJ using Vicryl 5/0#. One hour before surgery, anti-inflammatory medication was 
administered##. For pain control, postoperative analgesics were prescribed four times a day for 
3 days¶ ¶. 
In addition, patients were instructed to chlorhexidine (0.12 %) rinse twice a day for 1 
min and discontinue tooth brushing of the sites. Sutures were removed after 15 days and patients 
were instructed to resume tooth brushing with caution, using a soft toothbrush. All patients were 
enrolled in a periodontal maintenance program (professional plaque control and oral hygiene 
instruction) monthly during the 6 months. 
Statistical analysis 
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Sample size calculation for this superiority trial was performed considering root 
coverage as the primary outcome. The study was powered to detect a significant difference in 
root recession reduction among four groups (F test – ANOVA for repeated measurements: α = 
0.05, power = 80%, effect size = 0.443), based on data from previous studies to calculate the 
effect size 8,17,18. A total sample of 60 patients was required in the present trial. No subjects 
were lost to follow-up during the 6 months. After the completion of the study, considering the 
SD of each group, the power values were confirmed to be >80% to detect a difference in 
recession reduction (Rec Red) between the four groups. 
Descriptive statistical analysis was expressed by mean ± standard deviation (SD), 
percentages and confidence intervals (CI 95%). To verify the hypothesis of association between 
the group distributions, the Fisher exact test was performed for the proportions of gender, 
operated teeth and complete coverage. McNemar test was used to compare correlated samples 
for complete coverage. The treatments were compared by means of analysis of variance. 
Initially, the diagnosis was made to analyze the normality of the residue by the Shapiro-Wilk 
test. In the presence of normal distribution, the analysis of variance was performed for the 
parameters Age, FMPI and FMBI. When one effect was observed, the effect of the factor was 
analyzed, comparing the means by Tukey test. In cases where it was not possible to obtain 
normality of the residue, the analysis was performed using non-parametric statistics through the 
Kruskal-Wallis test for the remaining parameters. For analysis of only two factors it was used 
Mann-Whitney U. A significance level of 5% was adopted for all tests (α <0.05). No center-
effect on the treatment outcomes could be statistically demonstrated. 
Results 
A flow diagram of participants in the study is enclosed (Fig. 1). Table 1 shows the 
characteristics of the included subjects at baseline. This study included 68 patients (mean age: 
37.53), enrolled and treated between October 2013 and April 2016. 61% were female, and 51% 
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of the teeth were premolars. Baseline patient- and clinical-related characteristics did not present 
any significant difference among groups (p > 0.05). FMPI and FMBI were maintained below 
20% during the study period. The sites included in the study did not show bleeding on probing 
or visible plaque during the entire study period. All clinical parameters at baseline, 90 days and 
6 months are shown in Table 2. No significant adverse events were observed. 
 
Figure 1. Flowchart of the RCT according to CONSORT. 
Table 1. Patients characteristics at the baseline (n=68) 
Characteristic CAF CAF+CM CAF+EMD CAF+CM+EMD p 
Age mean± SD 38,12 ± 12,95 39,47 ± 10,94 39,29 ± 10,23 33,24 ± 10,41 0,331 
Gender 
 
Female 11 (64,71%) 10 (58,82%) 10 (58,82%) 11 (64,71%) 0,969 
Male 6 (35,29%) 7 (41,18%) 7 (41,18%) 6 (35,29%) 
Teeth Canine 6 (35,29%) 9 (52,94%) 7 (41,18%) 11 (64,71%) 0,324 
Premolar 11 (64,71%) 8 (47,06%) 10 (58,82%) 6 (35,29%) 
FMPI 
 
mean± SD 14,61 ± 5,26 13,67 ± 2,69 14,48 ± 2,13 11,91 ± 2,92 0,099 
95% CI (11,91 - 17,31) (12,29 - 15,06) (13,38 - 15,57) (10,41 - 13,42) 
FMBI 
 
mean± SD 10,35 ± 3,63 13,16 ± 5,42 12,43 ± 6,13 9,85 ± 2,36 0,120 
95% CI (8,48 - 12,21) (10,37 - 15,95) (9,27 - 15,58) (8,64 - 11,07) 
p values testing differences between treatment groups were calculated using ANOVA/Tukey for Age, FMPI and FMBI. P values for Gender and Teeth were 
obtained by Fisher Exact  Test. (α <0.05) 
CAF coronally advanced flap, CM porcine collagen matrix, EMD Enamel matrix derivative, SD standard deviation, FMPI full-mouth plaque index, FMBI full-
mouth bleeding index 
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Pocket depth  
PD was practically unaffected in all groups throughout the study without any 
statistically significant difference over time and among the groups. 
Clinical attachment level  
In the CAF group, CAL changed from 4,72 ± 0,86 mm at baseline to 2,54 ± 1,21 mm at 
6 months, corresponding to a gain of 2,18 ± 1,11 mm. CM group changed from 4,56 ± 0,68 mm 
to 1,69 ± 0,47 mm (Cal gain of 2,87 ± 0,75). For the EMD treated group, CAL changed from 
4,51 ± 0,59 mm to 1,81 ± 0,82 mm, corresponding to a gain of 2,70 ± 0,84 mm. In the EMD+CM 
group, a CAL gain of 2,91 ± 0,87 mm was observed, after changing from 4,66 ± 0,53 mm at 
baseline to 1,75 ± 0,67 mm at 6 months. The changes from baseline to 90 days and 6 months 
were significant (p<0.001) in all groups, although there was no significant difference among 
them. 
Table 2. Clinical results in mm (n=68) 
Parameters CAF  
mean± SD 
(95% CI) 
CAF+CM 
mean± SD 
(95% CI) 
CAF+EMD 
mean± SD 
(95% CI) 
CAF+CM+EMD 
mean± SD 
(95% CI) 
p 
PD Baseline 1,50 ± 0,75 1,44 ± 0,56 1,47 ± 0,48 1,50 ± 0,50 0,968 
(1,11 - 1,89) (1,16 - 1,73) (1,22 - 1,72) (1,24 - 1,76) 
 
90d 1,50 ± 0,56 1,44 ± 0,66 1,53 ± 0,6 1,53 ± 0,5 0,913 
(1,21 - 1,79) (1,1 - 1,78) (1,22 - 1,84) (1,27 - 1,8) 
 
180d 1,47 ± 0,54 1,26 ± 0,44 1,44 ± 0,50 1,47 ± 0,48 0,552 
(1,19 - 1,75) (1,04 - 1,49) (1,19 - 1,7) (1,22 - 1,72) 
 
90d-baseline 0,00 ± 0,68 0,00 ± 0,64 0,06 ± 0,73 -0,06 ± 0,58 0,93 
(-0,35 - 0,35) (-0,33 - 0,33) (-0,31 - 0,43) (-0,36 - 0,24) 
 
180d-baseline -0,03 ± 0,74 -0,18 ± 0,50 -0,03 ± 0,67 -0,03 ± 0,60 0,820 
(-0,41 - 0,35) (-0,43 - 0,08) (-0,38 - 0,32) (-0,34 - 0,28) 
 
180d-90d -0,03 ± 0,37 -0,18 ± 0,43 -0,09 ± 0,54 0,03 ± 0,45 0,639 
(-0,22 - 0,16) (-0,40 - 0,05) (-0,36 - 0,19) (-0,20 - 0,26) 
 
       
CAL Baseline 4,72 ± 0,86 4,56 ± 0,68 4,51 ± 0,59 4,66 ± 0,53 0,728 
 (4,28 - 5,16) (4,22 - 4,91) (4,20 - 4,81) (4,39 - 4,93) 
 
90d 2,40 ± 1,11 1,83 ± 0,79 1,84 ± 0,86 1,79 ± 0,72 0,302 
(1,83 - 2,96) (1,43 - 2,24) (1,40 - 2,28) (1,41 - 2,16) 
 
180d 2,54 ± 1,21 1,69 ± 0,47 1,81 ± 0,82 1,75 ± 0,67 0,079 
(1,92 - 3,16) (1,45 - 1,93) (1,39 - 2,23) (1,40 - 2,10) 
 
90d-baseline -2,32 ± 0,93* -2,73 ± 0,92* -2,66 ± 0,86* -2,88 ± 0,81* 0,360 
(-2,8 - -1,85) (-3,21 - -2,25) (-3,11 - -2,22) (-3,29 - -2,46) 
 
180d-baseline -2,18 ± 1,11* -2,87 ± 0,75* -2,70 ± 0,84* -2,91 ± 0,87* 0,214 
(-2,75 - -1,61) (-3,26 - -2,48) (-3,13 - -2,27) (-3,36 - -2,46) 
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180d-90d 0,15 ± 0,43 -0,14 ± 0,56 -0,03 ± 0,53 -0,04 ± 0,48 0,099 
(-0,07 - 0,37) (-0,43 - 0,15) (-0,30 - 0,24) (-0,28 - 0,21) 
 
       
GR Baseline 3,22 ± 0,45 3,12 ± 0,40 3,04 ± 0,31 3,16 ± 0,33 0,427  
(2,99 - 3,45) (2,92 - 3,33) (2,88 - 3,2) (2,99 - 3,33) 
 
90d 0,88 ± 0,77a 0,38 ± 0,51b 0,31 ± 0,57b 0,33 ± 0,41b 0,044 
(0,49 - 1,28) (0,12 - 0,64) (0,02 - 0,61) (0,12 - 0,55) 
 
180d 1,06 ± 0,86a 0,41 ± 0,49b 0,37 ± 0,66b 0,26 ± 0,34b 0,008 
(0,62 - 1,49) (0,16 - 0,67) (0,03 - 0,71) (0,08 - 0,43) 
 
90d-baseline -2,34 ± 0,65* -2,74 ± 0,44* -2,72 ± 0,51* -2,83 ± 0,64* 0,101  
(-2,67 - -2,00) (-2,97 - -2,51) (-2,99 - -2,46) (-3,16 - -2,50) 
 
180d-baseline -2,16 ± 0,75*a -2,71 ± 0,51*b -2,67 ± 0,57*b -2,91 ± 0,53*b 0,020  
(-2,55 - -1,78) (-2,97 - -2,45) (-2,96 - -2,37) (-3,18 - -2,63) 
 
180d-90d 0,17 ± 0,19*a 0,03 ± 0,33b 0,05 ± 0,12b -0,08 ± 0,24b 0,001 
(0,08 - 0,27) (-0,14 - 0,2) (-0,01 - 0,12) (-0,2 - 0,05) 
 
       
KTW Baseline 2,86 ± 1,30 2,58 ± 1,47 2,59 ± 1,43 2,32 ± 1,07 0,747  
(2,19 - 3,53) (1,83 - 3,34) (1,85 - 3,32) (1,77 - 2,87) 
 
90d 3,07 ± 1,25 2,67 ± 1,20 2,66 ± 0,98 2,61 ± 0,72 0,735 
(2,42 - 3,71) (2,06 - 3,29) (2,15 - 3,16) (2,24 - 2,98) 
 
180d 3,16 ± 1,26 2,93 ± 1,18 2,95 ± 1,07 2,65 ± 0,70 0,664 
(2,51 - 3,81) (2,33 - 3,54) (2,40 - 3,5) (2,30 - 3,01) 
 
90d-baseline 0,21 ± 1,35 0,09 ± 1,11 0,07 ± 0,94 0,29 ± 0,82 0,879 
(-0,49 - 0,90) (-0,48 - 0,66) (-0,41 - 0,55) (-0,13 - 0,71) 
 
180d-baseline 0,30 ± 1,4 0,35 ± 1,04 0,36 ± 0,9 0,34 ± 0,86 0,996 
(-0,42 - 1,02) (-0,19 - 0,89) (-0,1 - 0,82) (-0,11 - 0,78) 
 
180d-90d 0,09 ± 0,28 0,26 ± 0,68 0,29 ± 0,52 0,05 ± 0,47 0,143 
(-0,05 - 0,24) (-0,09 - 0,61) (0,03 - 0,56) (-0,19 - 0,29) 
 
       
KTT Baseline 0,94 ± 0,30 0,84 ± 0,26 0,88 ± 0,26 0,92 ± 0,19 0,596  
(0,78 - 1,1) (0,71 - 0,97) (0,75 - 1,02) (0,82 - 1,02) 
 
90d 1,16 ± 0,39 1,17 ± 0,42 0,99 ± 0,18 1,20 ± 0,27 0,236 
(0,96 - 1,35) (0,96 - 1,39) (0,9 - 1,09) (1,06 - 1,34) 
 
180d 1,07 ± 0,35 1,20 ± 0,40 1,00 ± 0,21 1,22 ± 0,26 0,092 
(0,89 - 1,25) (0,99 - 1,40) (0,89 - 1,11) (1,08 - 1,35) 
 
90d-baseline 0,22 ± 0,33* 0,33 ± 0,51* 0,11 ± 0,25 0,28 ± 0,33* 0,633 
(0,05 - 0,39) (0,07 - 0,59) (-0,02 - 0,24) (0,11 - 0,45) 
 
180d-baseline 0,13 ± 0,32 0,36 ± 0,47* 0,12 ± 0,27 0,30 ± 0,31* 0,139 
(-0,04 - 0,29) (0,11 - 0,60) (-0,02 - 0,26) (0,14 - 0,46) 
 
180d-90d -0,09 ± 0,34 0,02 ± 0,12 0,01 ± 0,10 0,02 ± 0,04 0,520 
(-0,26 - 0,09) (-0,04 - 0,09) (-0,05 - 0,06) (0,00 - 0,04) 
 
P value obtained using Kruskal–Wallis H test. Different letters indicate significant differences between groups by Mann–Whitney U test (p < 0.05). Asterisk 
indicates differences within groups over time by Wilcoxon signed-rank test (α <0.05) 
CAF coronally advanced flap, CM porcine collagen matrix, EMD Enamel matrix derivative, SD standard deviation, CI confidence interval, PD probing depth, 
CAL clinical attachment level , GR gingival recession depth, KTW keratinized tissue width, KTT keratinized tissue thickness. 
 
Gingival recession 
At CAF treated sites, GR decreased from 3,22 ± 0,45 mm at baseline to 1,06 ± 0,86 mm 
at 6 months post-operative corresponding to a mean root coverage (MRC) of 68,04 ± 24,11 % 
(GR reduction of 2,16 ± 0,75 mm). At CM treated sites, GR changed from 3,12 ± 0,40 mm to 
0,41 ± 0,49 mm, corresponding to a MRC of 87,2 ± 15,01 %. At EMD treated sites, GR at 
24 
 
baseline was 3,04 ± 0,31 mm and decreased to 0,37 ± 0,66 mm at 6 months, showing a MRC 
of 88,77 ± 20,66 %. When CM and EMD were combined for the treatment of gingival 
recessions, the GR decreased from 3,13 ± 0,37 mm to 0,26 ± 0,34 mm, corresponding to a MRC 
of 91,59 ± 11,08 % (GR gain of 2,91 ± 0,53 mm) at 6 months. 
From 90 days to 6 months, MRC decreased significantly from 73,46% to 68,04% 
(p<0,05) in the CAF group (GR increased 0,17 ± 0,19mm). Whereas, in CM and EMD groups 
slightly decreased from 88,6 % and 90,38 % to 87,2 % and 88,77 % respectively. In the 
CM+EMD group, MRC increased from 88,82 % to 91,59 %. 
CRC achieved in the EMD group was 70,59 % (12/17), significantly superior to CAF, 
23,53 % (4/17); CM, 52,94 % (9/17), and CM+EMD group, 58,82 % (10/17) after 6 months 
(Table 3). Reduction of the recession was significant for all groups from baseline to 90 days 
and 6 months, however CAF reduction was statistically smaller than all the others (p<0,05).  
Keratinized Tissue 
For KTW, CAF group changed from 2,86 ± 1,30 mm at baseline to 3,16 ± 1,26 mm at 
6 months (KTW gain of 0,30 ± 1,40 mm). In the CM group, KTW changed from 2,58 ± 1,47 
mm to 2,93 ± 1,18 mm, corresponding to a gain of 0,35 ± 1,04 mm. For the EMD group, the 
change was from 2,59 ± 1,43 mm to 2,95 ± 1,07 mm (a gain of 0,36 ± 0,90 mm). In the CM 
+EMD group, the tissue width changed from 2,32 ± 1,07 mm at baseline to 2,65 ± 0,70 mm at 
6 months (a gain of 0,34 ± 0,86 mm).  The changes from baseline to 90 days and 6 months were 
not statistically significant (p>0,05). 
Table 3. Percentage of root coverage (n=68) 
  CAF 
mean± SD 
(95% CI) 
CAF+CM 
mean± SD 
(95% CI) 
CAF+EMD 
mean± SD 
(95% CI) 
CAF+CM+EMD 
mean± SD 
(95% CI) 
P 
Average % root coverage 
90d 73,46 ± 21a 88,6 ± 15,04b 90,38 ± 17,97b 88,82 ± 14,23b 0,018 
(62,66 - 84,26) (80,87 - 96,34) (81,14 - 99,62) (81,51 - 96,14) 
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180d 68,04 ± 24,11a 87,2 ± 15,01b 88,77 ± 20,66b 91,59 ± 11,08b 0,001 
(55,64 - 80,44) (79,48 - 94,91) (78,15 - 99,39) (85,9 - 97,29) 
P between time 0,002 0,579 0,08 0,19 
 
Patients with 100% coverage 
90d 5 (29,41 %)a 10 (58,82 %)a 12 (70,59 %)b 9 (52,94 %)a 0,105 
180d 4 (23,53 %)a 9 (52,94 %)a 12 (70,59 %)b 10 (58,82 %)b 0,042 
P between time 0,977 
 
P values are obtained using Kruskal–Wallis H test for intergroup comparisons and Wilcoxon signed-rank test for intragroup average percentage of root coverage. 
Patients with 100% coverage - Fisher Exact  Test for intergroup comparisons and McNemar test comparing correlated samples. (α <0.05) 
CAF coronally advanced flap, CM porcine collagen matrix, EMD Enamel matrix derivative, SD standard deviation, CI confidence interval 
 
 For KTT, CAF group changed from 0,94 ± 0,30 mm at baseline to 1,07 ± 0,35 mm at 6 
months, corresponding to a gain of 0,13 ± 0,32 mm. In the CM group, KTT changed from 0,84 
± 0,26 mm to 1,20 ± 0,40 mm, a thickness gain of 0,36 ± 0,47 mm. For the EMD group, 0,88 ± 
0,26 mm at baseline to 1,00 ± 0,21 mm (a gain of 0,12 ± 0,27 mm). In the CM +EMD group, 
the tissue thickness changed from 0,92 ± 0,19 mm at baseline to 1,22 ± 0,26 mm at 6 months, 
corresponding to 0,30 ± 0,31 mm of gain.  The changes from baseline to 90 days were 
significant to CAF, CM and CM+EMD (p<0.05), however, at 6 months only CM and 
CM+EMD significantly increased the KTT (P<0.05). 
Table 4. Professional esthetic evaluation (n=68) 
  CAF 
mean± SD 
(95% CI) 
CAF+CM 
mean± SD 
(95% CI) 
CAF+EMD 
mean± SD 
(95% CI) 
CAF+CM+EMD 
mean± SD 
(95% CI) 
p 
RES 7,71 ± 2,02 8,29 ± 2,54 7,82 ± 3 8,47 ± 1,59 0,645 
 
(6,67 - 8,75) (6,99 - 9,6) (6,28 - 9,37) (7,66 - 9,29) 
VAS 8,29 ± 1,36 8,65 ± 1,58 9,00 ± 1,22 8,82 ± 1,01 0,427 
 
(7,6 - 8,99) (7,84 - 9,46) (8,37 - 9,63) (8,3 - 9,35) 
P values are obtained using Kruskal–Wallis H test for intergroup comparisons (α <0.05) CAF coronally advanced flap, CM porcine collagen matrix, EMD 
Enamel matrix derivative, SD standard deviation, CI confidence interval, RES Root Coverage Esthetic Score, QCE Qualitative Cosmetic Evaluation 
Esthetic evaluation  
For the professional aesthetic evaluation, the outcomes were estimated using RES and 
VAS. These objective measurements showed no statistically significant difference (p>0,05) 
among the groups (Table 4). 
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Figure 2. Baseline and final aspect at 6-months for (a) CAF; (b) CM; (c) EMD and (d) 
CM+EMD groups. 
Discussion 
As alternatives to the use of autogenous grafts, several biomaterials have been studied 
for the treatment of localized gingival recessions19. All tested approaches achieved a 
considerable percentage of root coverage (68,04 ± 24,11% for CAF, 87,2 ± 15,01% for 
CAF+CM, 88,77 ± 20,66% for CAF+EMD and 91,59 ± 11,08% for CAF+CM+EMD). This 
difference was significant (CAF versus other groups), however the groups receiving 
biomaterials did not present difference among them. Hence, the hypothesis of an enhanced 
outcome by the combined use of the CM+EMD could not be confirmed.  
In order to evaluate the additional benefit of CM in the CAF procedure for root coverage, 
Jepsen et al. (2013) reported a MRC of 75.3% for CAF+CM and 72,66% for CAF defects10. 
Moreira et al. (2016) showed 77.2% for CAF +CM group and 72.1 % for CAF group8. None of 
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these previous RCTs found significant difference between groups, what is not in accordance 
with the present study, where CM group was better than CAF alone for root coverage, after 6 
months. When CM was compared to the gold-standard treatment (SCTG), McGuire & Scheyer 
(2010) showed that the results in terms of aesthetic outcomes and patient satisfaction were good 
in both groups, the MRC was significantly superior for the CAF + SCTG procedure (99.3% 
versus 88.5% for CM)9. Cardaropoli et al. (2012) presented a MRC of 94.3% for CM group and 
96.9% for SCTG group20. This percentages for CM groups were comparable to the one achieved 
in the present study. 
Some studies have evaluated the outcomes of EMD associated to CAF procedures. The 
improvements observed in this study for EMD groups are consistent with the results obtained 
by Spahr et al. (2005) (84% for EMD group and 67% for CAF group)17; Del Pizzo et al. (2005) 
(90.6% for EMD and 86.7% for CAF group) and Cordaro et al. (2012) (82.8% for EMD and 
80.7% for CAF) after 24-month follow-up21,22. However, Spahr et al. (2005) was able to achieve 
a significant difference regarding the stability of EMD, whereas 47% of gingival recessions 
treated with CAF alone deteriorated after two years, compared with 22% of root coverage 
relapse in the test group17. As observed in this study, from 90 to 180 days, the CAF group was 
less stable than the others, demonstrating a significant difference in gingival recession. This 
deterioration is less frequently when SCTG-based procedures or soft tissue graft substitutes are 
used 4.  
When EMD was compared to SCTG for MRC, Alkan & Parlar (2011) achieved 92% 
for EMD and 89% for SCTG and Moses et al. (2006) obtained 73.2% for EMD and 86.8% for 
SCTG, comparable to the %RC obtained in this study23,24. The influence of EMD when 
associated with SCTG was reported also. Rasperini et al. (2011) described root coverage rates 
of 90% for SCTG plus EMD and 80% for STCG groups after 1 year25. In contrast, Roman et 
al. (2013) observed 82.3% for SCTG plus EMD and 89.8% for SCTG alone18. For these studies, 
28 
 
the adjunctive use of EMD with SCTG didn’t show any significant additional benefit. Actually, 
although the use of EMD produced a significant improvement of CAF alone, the multiple 
combinations, using more than a single graft/biomaterial under the flap, may present 
comparable or less benefits than simpler procedures19. To the best of our knowledge, this is the 
first RCT that compared the isolated and combined use of EMD and CM at the same trial.  
Complete root coverage is the ultimate goal in the treatment of localized gingival 
recessions and has been considered as an ideal outcome after root coverage procedures15. Data 
in the present trial revealed that CRC was achieved in 70.59% and 58.82% of the patients treated 
with CAF plus EMD or CAF+CM+EMD, respectively; and was statistically different from CAF 
(23.53%), but with no difference from CAF+CM (52.94%). Thus, the use of EMD enhanced 
the clinical outcome for complete root coverage compared to CAF alone. Clearly, before a more 
definitive conclusion can be made, the stability of the results must be evaluated over longer 
periods of time, at least 2 years of follow-up.  
Del Pizzo et al. (2005) obtained no significant differences between EMD and control 
groups, though CRC was achieved in 73.3% for CAF plus EMD group and in 60.0% for CAF 
group21. When compared to SCTG, McGuire et al. (2012) obtained CRC in 89.5% for EMD 
and in 79% for SCTG27. Rasperini et al. (2011) achieved 61.5% for SCTG+EMD and 46.7 for 
SCTG alone25. For CM, the percentage of sites showing CRC described by Cardaropoli et al. 
(2012) was 72 % for CM and 81% for SCTG20. On the other hand, data reported by Jepsen et 
al. (2013) showed 31 % for CAF and 36% for CAF + CM10. Moreira et al. (2016) found 35% 
for CAF and 40% for CM group8. In a recent systematic review11, Cairo et al. (2008)  described 
that no treatment, except for CAF plus EMD, achieved a comparable SCTG efficacy for 
complete root coverage.   
The rationale for using EMD in root coverage procedures, in addition to its clinical 
characteristics, is the possibility to regenerate the lost periodontal tissues, as demonstrated in 
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several studies with histological evaluation in animals and humans, with the formation of new 
bone, cementum and periodontal ligament, rather than periodontal repair13,14,28,29. Recently, a 
study with human histologic examination evaluated the difference in regeneration capacity 
between EMD and SCTG. The sites treated with EMD exhibited varying degrees of periodontal 
regeneration whereas none of the teeth treated with SCTG showed regeneration, despite similar 
clinical outcomes 13. 
The present study, in alignment to Aroca et al. (2010), Henriques et al. (2010) and 
Moreira et al. (2016) didn’t demonstrate additional keratinized tissue width (KTW) gain8,30,31. 
After one year, increased KTW have been reported for CM associated to CAF procedure. 
McGuire & Scheyer (2010) and Cardaropoli et al. (2012), reported a gain of 1.34 mm and 1.23 
mm, respectively when CM was used9,20. Jepsen et al. (2013) observed that the CM treated 
group mean width after 6 months was 0.37 mm greater than the observed with CAF10. When 
EMD was used, Del Pizzo et al. (2005) observed an increase over time of 1.00mm, whereas the 
control group increased 0.47mm21. Cordaro et al. (2012) found a gain of 0.31mm and 0.28mm 
for CAF and CAF+EMD, respectively22. Still, none of the treatments evaluated in this RCT 
significantly change the KTW. The possible reason is that, MGJ identification procedure might 
be different among studies.  In this study, it was performed after iodine solution stain, which 
may be different from the functional method32. 
The CM use resulted in significantly gain in gingival thickness of keratinized tissue, 
when compared to baseline values while CAF and EMD groups did not show significant KTT 
change after 6 months. Moreira et al. (2016) reported a gain of 0.14 for CAF and 0.40 for CM 
after 6 months8. Jepsen et al. (2013) observed a gain of 0.59 and 0.34 mm for CM and CAF 
alone, respectively10. Ahmedbeyli et al. (2014) showed that increasing KTT (‘‘biotype 
modification’’) might be an important outcome, once a thin gingival biotype may be related to 
the risk for gingival recession33. Chambrone & Tatakis (2015) recently reviewed root coverage 
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procedure outcomes and reported that increase in KTT can prevent gingival recession 
recurrence at long-term4. However, it is also interesting to note that this observed increase might 
be considered clinically modest.  
In terms of esthetic outcome after the surgeries, the visual analog scale (VAS) and the 
root coverage aesthetic score (RES)15 were applied to sets of clinical pictures (baseline/6 
months) by four independent periodontists. This assessment confirmed no differences in 
aesthetics appearance among all treatment groups and an improved professional perception of 
aesthetics after the procedures.  
 
Conclusions 
It can be concluded that, the associations of CAF+CM, CAF+EMD and 
CAF+CM+EMD resulted in superior clinical outcomes regarding root coverage in comparison 
to CAF alone. Nevertheless, CAF+EMD and CAF+CM+EMD obtained highest levels of 
complete root coverage. The use of CM is associated with a slight (but significant) increase in 
gingival thickness that was not observed for CAF+EMD or CAF alone. The combined approach 
does not seem justified in terms of root coverage.  
 
Footnotes 
* MS, PhD student - Division of Periodontics - Piracicaba Dental School, State University of 
Campinas 
** MS, PhD student - Division of Periodontics - State University of São Paulo Campus São José 
dos Campos, Brazil 
31 
 
† DDS, MS student - Division of Periodontics - Piracicaba Dental School, State University of 
Campinas 
‡ PhD, Assistant professor - Division of Periodontics - Piracicaba Dental School, State 
University of Campinas 
‡‡ PhD, Assistant professor - Division of Periodontics - State University of São Paulo Campus 
São José dos Campos, Brazil 
§ PhD, Full professor - Division of Periodontics - Piracicaba Dental School, State University 
of Campinas 
§§ Mucograft®; Geistlich Pharma AG, Wolhusen, Switzerland 
‖ Emdogain®, Institut Straumann AG, Basel, Switzerland 
†† Hu-Friedy, Jacarepaguá, Rio de Janeiro, Brazil. 
¶ Absolute, Mitutoyo Sul Americana, Suzano, São Paulo, Brazil. 
*** Shiller’s, Proderma Farmácia de Manipulação, Piracicaba, São Paulo, Brazil. 
# Johnson & Johnson, Skillman, NJ, USA. 
## Dexamethasone 4 mg, Ache Pharmaceutical Laboratories SA, Guarulhos, SP 
¶ ¶ Dipyrone 500 mg, Ache Pharmaceutical Laboratories SA, Guarulhos, SP ## Perio-Bond®, 
Dentsply, Petrópolis, Rio de Janeiro, Brazil. 
Acknowledgments 
The authors appreciate the financial support provided by the Research Funding Agency from 
São Paulo State (FAPESP), São Paulo, SP, Brazil - Grant 2013/19473-6. The authors report no 
conflicts of interest related to this study. 
32 
 
References 
1.  Chambrone L, Tatakis DN. Long-term Outcomes of Untreated Buccal Gingival 
Recessions. A Systematic Review and Meta-Analysis. Journal of Periodontology. 
2016;87(7):1-17. doi:10.1902/jop.2016.150625. 
2.  Azaripour A, Kissinger M, Farina VSL, et al. Root coverage with connective tissue 
graft associated with coronally advanced flap or tunnel technique. A randomized, 
double blind, mono-center clinical trial. Journal of Clinical Periodontology. 
2016:1142-1150. doi:10.1111/jcpe.12627. 
3.  Cairo F, Pagliaro U, Buti J, et al. Root coverage procedures improve patient aesthetics. 
A systematic review and Bayesian network meta-analysis. Journal of Clinical 
Periodontology. 2016:965-975. doi:10.1111/jcpe.12603. 
4.  Chambrone L, Tatakis DN. Periodontal Soft Tissue Root Coverage Procedures: A 
Systematic Review From the AAP Regeneration Workshop. Journal of 
Periodontology. 2015;86(2-s):S8-S51. doi:10.1902/jop.2015.130674. 
5.  Buti J, Baccini M, Nieri M, La Marca M, Pini-Prato GP. Bayesian network meta-
analysis of root coverage procedures: Ranking efficacy and identification of best 
treatment. Journal of Clinical Periodontology. 2013;40:372-386. 
doi:10.1111/jcpe.12028. 
6.  Chambrone L, Sukekava F, Araújo MG, Pustiglioni FE, Chambrone LA, Lima L a. 
Root-coverage procedures for the treatment of localized recession-type defects: a 
Cochrane systematic review. The Journal of periodontology. 2010;81(4):452-478. 
doi:10.1902/jop.2010.090540. 
7.  Gobbato L, Nart J, Bressan E, Mazzocco F, Paniz G, Lops D. Patient morbidity and 
33 
 
root coverage outcomes after the application of a subepithelial connective tissue graft 
in combination with a coronally advanced flap or via a tunneling technique: a 
randomized controlled clinical trial. Clinical oral investigations. 2016;20(8):2191-
2202. doi:10.1007/s00784-016-1721-7. 
8.  Moreira ARO, Santamaria MP, Silvério KG, et al. Coronally advanced flap with or 
without porcine collagen matrix for root coverage: a randomized clinical trial. Clinical 
Oral Investigations. 2016:1-11. doi:10.1007/s00784-016-1757-8. 
9.  McGuire MK, Scheyer ET. Xenogeneic collagen matrix with coronally advanced flap 
compared to connective tissue with coronally advanced flap for the treatment of 
dehiscence-type recession defects. The Journal of periodontology. 2010;81(8):1108-
1117. doi:10.1902/jop.2010.090698. 
10.  Jepsen K, Jepsen S, Zucchelli G, et al. Treatment of gingival recession defects with a 
coronally advanced flap and a xenogeneic collagen matrix: A multicenter randomized 
clinical trial. Journal of Clinical Periodontology. 2013;40(1):82-89. 
doi:10.1111/jcpe.12019. 
11.  Cairo F, Pagliaro U, Nieri M. Treatment of gingival recession with coronally advanced 
flap procedures: a systematic review. Journal of clinical periodontology. 2008;35(8 
Suppl):136-162. doi:10.1111/j.1600-051X.2008.01267.x. 
12.  Koop R, Merheb J, Quirynen M. Periodontal Regeneration With Enamel Matrix 
Derivative in Reconstructive Periodontal Therapy: A Systematic Review. Journal of 
Periodontology. 2012;83(June):707-720. doi:10.1902/jop.2011.110266. 
13.  McGuire MK, Scheyer ET, Schupbach P. A Prospective, Cased-Controlled Study 
Evaluating the use of Enamel Matrix Derivative on Human Buccal Recession Defects: 
A Human Histologic Examination. Journal of Periodontology. 2016:1-34. 
34 
 
doi:10.1902/jop.2016.150459. 
14.  Sallum E a., Pimentel SP, Saldanha JB, et al. Enamel Matrix Derivative and Guided 
Tissue Regeneration in the Treatment of Dehiscence-Type Defects: A 
Histomorphometric Study in Dogs. Journal of Periodontology. 
2004;75(October):1357-1363. doi:10.1902/jop.2004.75.10.1357. 
15.  Cairo F, Nieri M, Cattabriga M, et al. Root coverage esthetic score after treatment of 
gingival recession: an interrater agreement multicenter study. The Journal of 
periodontology. 2010;81(12):1752-1758. doi:10.1902/jop.2010.100278. 
16.  De Sanctis M, Zucchelli G. Coronally advanced flap: A modified surgical approach for 
isolated recession-type defects: Three-year results. Journal of Clinical Periodontology. 
2007;34:262-268. doi:10.1111/j.1600-051X.2006.01039.x. 
17.  Spahr A, Haegewald S, Tsoulfidou F, et al. Coverage of Miller class I and II recession 
defects using enamel matrix proteins versus coronally advanced flap technique: a 2-
year report. The Journal of periodontology. 2005;76(November):1871-1880. 
doi:10.1902/jop.2005.76.11.1871. 
18.  Roman  a., Soancǎ  a., Kasaj  a., Stratul SI. Subepithelial connective tissue graft with or 
without enamel matrix derivative for the treatment of Miller class I and II gingival 
recessions: A controlled randomized clinical trial. Journal of Periodontal Research. 
2013;48:563-572. doi:10.1111/jre.12039. 
19.  Cairo F, Nieri M, Pagliaro U. Efficacy of periodontal plastic surgery procedures in the 
treatment of localized facial gingival recessions. A systematic review. Journal of 
clinical periodontology. 2014;41 Suppl 1:S44-62. doi:10.1111/jcpe.12182. 
20.  Cardaropoli D, Tamagnone L, Roffredo A, Gaveglio L. Treatment of Gingival 
35 
 
Recession Defects Using Coronally Advanced Flap With a Porcine Collagen Matrix 
Compared to Coronally Advanced Flap With Connective Tissue Graft: A Randomized 
Controlled Clinical Trial. Journal of Periodontology. 2012;83(March):321-328. 
doi:10.1902/jop.2011.110215. 
21.  Del Pizzo M, Zucchelli G, Modica F, Villa R, Debernardi C. Coronally advanced flap 
with or without enamel matrix derivative for root coverage: A 2-year study. Journal of 
Clinical Periodontology. 2005;32(11):1181-1187. doi:10.1111/j.1600-
051X.2005.00831.x. 
22.  Cordaro L, di Torresanto VM, Torsello F. Split-mouth comparison of a coronally 
advanced flap with or without enamel matrix derivative for coverage of multiple 
gingival recession defects: 6- and 24-month follow-up. The International journal of 
periodontics & restorative dentistry. 2012;32:e10-20. 
http://www.ncbi.nlm.nih.gov/pubmed/22254230. 
23.  Alkan E a., Parlar  a. EMD or subepithelial connective tissue graft for the treatment of 
single gingival recessions: A pilot study. Journal of Periodontal Research. 
2011;46(1):637-642. doi:10.1111/j.1600-0765.2011.01381.x. 
24.  Moses O, Artzi Z, Sculean A, et al. Comparative study of two root coverage 
procedures: a 24-month follow-up multicenter study. Journal of periodontology. 
2006;77(2):195-202. doi:10.1902/jop.2006.050008. 
25.  Rasperini G, Roccuzzo M, Francetti L, Acunzo R, Consonni D, Silvestri M. 
Subepithelial connective tissue graft for treatment of gingival recessions with and 
without enamel matrix derivative: a multicenter, randomized controlled clinical trial. 
The International journal of periodontics & restorative dentistry. 2011;31(2):133-139. 
26.  McGuire M, Scheyer E, Nunn ME. Evaluation of Human Recession Defects Treated 
36 
 
With Coronally Advanced Flaps and Either Enamel Matrix Derivative or Connective 
Tissue: Comparison of Clinical Parameters at 10 Years. J Periodontol. 
2012;83(November):1353-1362. 
27.  McGuire MK, Scheyer ET, Nunn M. Evaluation of human recession defects treated 
with coronally advanced flaps and either enamel matrix derivative or connective tissue: 
comparison of clinical parameters at 10 years. Journal of periodontology. 
2012;83(11):1353-1362. doi:10.1902/jop.2012.110373. 
28.  Sculean A, Windisch P, Szendröi-Kiss D, et al. Clinical and histologic evaluation of an 
enamel matrix derivative combined with a biphasic calcium phosphate for the treatment 
of human intrabony periodontal defects. The Journal of periodontology. 
2008;79(October):1991-1999. doi:10.1902/jop.2008.080009. 
29.  Corrêa MG, Gomes Campos ML, Marques MR, Casati MZ, Nociti FH, Sallum E a. 
Histometric Analysis of the Effect of Enamel Matrix Derivative on the Healing of 
Periodontal Defects in Diabetic Rats. Journal of periodontology. 2012;1:1-18. 
doi:10.1902/jop.2012.120354. 
30.  Henriques PSG, Pelegrine AA, Nogueira AA, Borghi MM. Application of subepithelial 
connective tissue graft with or without enamel matrix derivative for root coverage: a 
split-mouth randomized study. Journal of oral science. 2010;52(3):463-471. 
31.  Aroca S, Keglevich T, Nikolidakis D, et al. Treatment of class III multiple gingival 
recessions: a randomized-clinical trial. Journal of clinical periodontology. 
2010;37(1):88-97. doi:10.1111/j.1600-051X.2009.01492.x. 
32.  Bernimoulin JP, Son S, Regolati B. Biometric comparison of three methods for 
determining the mucogingival junction. Helvetica odontologica acta. 1971;15(2):118-
120. 
37 
 
33.  Ahmedbeyli C, Ipci SD, Cakar G, Kuru BE, Yilmaz S. Clinical evaluation of coronally 
advanced flap with or without acellular dermal matrix graft on complete defect 
coverage for the treatment of multiple gingival recessions with thin tissue biotype. 
Journal of clinical periodontology. 2014;41(3):303-310. doi:10.1111/jcpe.12211. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
3 CONCLUSÃO 
 
Diante dos resultados apresentados, pode-se concluir que o retalho posicionado 
coronariamente associado à matriz de colágeno xenógena, proteínas da matriz do esmalte ou a 
associação destes; apresentaram melhores resultados clínicos em relação a redução da recessão 
gengival quando comparados ao retalho posicionado coronariamente sem biomateriais. Além 
disso, a utilização de apenas proteínas derivadas da matriz do esmalte alcançou maior 
porcentagem de sítios com recobrimento completo quando comparados aos outros tratamentos. 
A utilização da matriz de colágeno xenógena foi associada a um ganho significativo de 
espessura gengival. A associação dos biomateriais não promoveu benefícios adicionais para o 
tratamento das recessões gengivais.  
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